Table 3.
Parameter | HOMA-IR Unadjusted | HOMA-IR Demographic-adjusted* | HOMA-IR Fully adjusted** |
---|---|---|---|
% Estimate (95% CI) | % Estimate (95% CI) | % Estimate (95% CI) | |
HIV/HCV coinfected | |||
I-FABP (per doubling) | −3% (−11%, 5%) p=0.428 | −8% (−15%, 0%) p=0.044 | −5% (−12%, 2%) p=0.174 |
sCD163 (per doubling)§ | 30% (17%, 45%) p<0.001 | 25% (12%, 40%) p<0.001 | 19% (7%, 33%) p=001 |
sCD14 (per doubling)§ | −11% (−18%, −4%) p=0.002 | −9% (−15%, −2%) p=0.014 | 0% (−6%, 8%) p=0.833 |
1L-6 (per doubling)§ | 1% (−7%, 8%) p=0.884 | 2% (−5%, 11%) p=0.510 | 1% (−6%, 9%) p=0.758 |
HCV monoinfected | |||
I-FABP (per doubling) | −2% (−10%, 6%) p=0.597 | −7% (−14%, 1%) p=0.097 | −3% (−10%, 4%) P=0.397 |
sCD163 (per doubling)§ | 30% (18%, 44%) p<0.001 | 28% (16%, 42%) p<0.001 | 26% (15%, 39%) p<0.001 |
sCD14 (per doubling)§ | −9% (−14%, 0%) p=0.025 | −7% (−14%, 0%) p=0.61 | 4% (−4%, 12%) p=−0.341 |
1L-6 (per doubling)§ | 3% (−4%, 12%) p=0.392 | 4% (−4%, 13%) p=0.279 | 3% (−4%, 10%) P=0.359 |
HIV monoinfected | |||
I-FABP (per doubling) | −1% (−9%, 8%) p=0.931 | −6% (−14%, 2%) p=0.182 | −3% (−10%, 5%) p=0.49 |
sCD163 (per doubling)§ | 28% (16%, 41%) p<0.001 | 26% (14%, 39%) p<0.001 | 25% (14%, 37%) p<0.001 |
sCD14 (per doubling)§ | −8% (−14%, 0%) p=0.051 | −6% (−13%, 1%) p=0.089 | 1% (−6%, 10%) p=0.688 |
IL-6 (per doubling)§ | 3% (−5%, 10%) p=0.473 | 3% (−4%, 14%) p=0.343 | 3% (−4%, 11%) p=0.387 |
Uninfected | |||
I-FABP (per doubling) | −3% (−11%, 6%) p=0.560 | −8% (−16%, 0%) p=0.052 | −6% (−14%, 2%) p=0.113 |
sCD163 (per doubling)§ | 34% (21%, 49%) p<0.001 | 29% (16%, 43%) p<0.001 | 23% (11%, 36%) p=001 |
sCD14 (per doubling)§ | −10% (−16%, −3%) p=0.009 | −9% (−15%, −2%) p=0.014 | −4% (−8%, 6%) p=0.684 |
1L-6 (per doubling)§ | 3% (−4%, 12%) p=0.398 | 4% (−4%, 12%) p=0.302 | 3% (−5%, 10%) p=0.493 |
Multiple imputation by the Chained Equation method was used to impute missing outcome values
Adjusted for gender, age, race
Adjusted for age, gender, race, smoking, alcohol, BMI, waist circumference and estimated glomerular filtrate rate.
All markers of inflammation added individually not sequentially.